Clinical trials in Fullerton, CA

30 recruiting studies have a site in or near Fullerton, CA, California.

Top conditions here

All conditions

Showing 30 of 30 studies

RecruitingPhase 3NCT06623422

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Sponsor: Merck Sharp & Dohme LLC

Fullerton, CA · Long Beach, CA · Los Angeles, CA · +51 more sites

RecruitingPhase 3NCT07816367

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Sponsor: Kallyope Inc.

Canoga Park, CA · Chula Vista, CA · Fountain Valley, CA · +69 more sites

RecruitingPhase 3NCT06312176

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Sponsor: Merck Sharp & Dohme LLC

Fullerton, CA · La Jolla, CA · Los Alamitos, CA · +43 more sites

RecruitingPhase 3NCT06966700

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Sponsor: Merck Sharp & Dohme LLC

Burbank, CA · Clovis, CA · Fullerton, CA · +61 more sites

RecruitingPhase 3NCT07144280

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Sponsor: Pfizer

Berkeley, CA · Concord, CA · Encinitas, CA · +238 more sites

RecruitingPhase 3NCT07225504

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Sponsor: Novartis Pharmaceuticals

Fullerton, CA · Newport Beach, CA · West Hollywood, CA · +40 more sites

RecruitingPhase 2NCT07023289

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Sponsor: AbbVie

Fullerton, CA · Los Angeles, CA · +20 more sites

RecruitingPhase 3NCT06976203

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Sponsor: Bristol-Myers Squibb

Fullerton, CA · Irvine, CA · Los Angeles, CA · +28 more sites

RecruitingPhase 3NCT07299019

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

Sponsor: Zenas BioPharma (USA), LLC

Fullerton, CA · Torrance, CA · West Hollywood, CA · +23 more sites

RecruitingPhase 3NCT06216301

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Sponsor: NovoCure GmbH

Fullerton, CA · Newport Beach, CA · Sacramento, CA · +35 more sites

RecruitingPhase 3NCT07174310

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Sponsor: Hoffmann-La Roche

Fullerton, CA · La Jolla, CA · Los Angeles, CA · +50 more sites

RecruitingPhase 3NCT06742723

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Sponsor: AstraZeneca

Beverly Hills, CA · Canoga Park, CA · Concord, CA · +130 more sites

RecruitingPhase 3NCT07438496

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Sponsor: Janssen Research & Development, LLC

Beverly Hills, CA · Fullerton, CA · Hemet, CA · +35 more sites

RecruitingPhase 3NCT07213674

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Sponsor: Amgen

Duarte, CA · Fullerton, CA · +42 more sites

RecruitingPhase 1NCT07201558

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Sponsor: AstraZeneca

Fullerton, CA · +5 more sites

RecruitingPhase 2NCT07570862

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Sponsor: Fate Therapeutics

Beverly Hills, CA · Fontana, CA · Fullerton, CA · +9 more sites

RecruitingPhase 3NCT06252649

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Sponsor: Amgen

Fullerton, CA · Long Beach, CA · Los Alamitos, CA · +23 more sites

RecruitingPhase 1 / Phase 2NCT07800871

FT839 in Autoimmune Diseases

Sponsor: Fate Therapeutics

Fullerton, CA

RecruitingPhase 1NCT04221542

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Sponsor: Amgen

Duarte, CA · Fullerton, CA · San Francisco, CA · +22 more sites

RecruitingPhase 3NCT05232916

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Sponsor: Greenwich LifeSciences, Inc.

Duarte, CA · Fullerton, CA · Irvine, CA · +48 more sites

RecruitingPhase 3NCT06203210

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Sponsor: Daiichi Sankyo

Fullerton, CA · Los Angeles, CA · San Francisco, CA · +27 more sites

RecruitingPhase 1 / Phase 2NCT05098132

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Sponsor: Synthekine

Beverly Hills, CA · Fullerton, CA · La Jolla, CA · +30 more sites

RecruitingPhase 1NCT04389632

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Anaheim, CA · Fullerton, CA · +103 more sites

RecruitingPhase 1NCT07290036

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Sponsor: UCB Biopharma SRL

Apple Valley, CA · Covina, CA · Fullerton, CA · +27 more sites

RecruitingPhase 1NCT06308978

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Sponsor: Fate Therapeutics

Beverly Hills, CA · Fullerton, CA · Irvine, CA · +13 more sites

RecruitingPhase 2 / Phase 3NCT03851445

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Sponsor: SWOG Cancer Research Network

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +1226 more sites

RecruitingNot applicableNCT05297734

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Sponsor: Stanford University

Duarte, CA · Fresno, CA · Fruitdale, CA · +14 more sites

RecruitingPhase 1NCT06336902

Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer

Sponsor: University of Southern California

Fullerton, CA · Los Angeles, CA

RecruitingPhase 2NCT04553770

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Sponsor: Jonsson Comprehensive Cancer Center

Fullerton, CA · Los Alamitos, CA · Los Angeles, CA · +6 more sites

RecruitingPhase 4NCT06662994

High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy

Sponsor: Retina Consultants of Orange County

Fullerton, CA

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.